Username This is the name that will be displayed next to your photo for comments, blog posts, and more. Choose wisely! Email Your e-mail address will be used to confirm your account. We won t share it with anyone else. Password Create a password that only you will remember. If you forget it, you ll be able to recover it using your email address. Confirm Password
TEL AVIV, Israel and RALEIGH, N.C., May 27, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today reported its financial results and operational highlights for the first quarter ended March 31, 2021.
Dror Ben-Asher, RedHill s Chief Executive Officer, said: The progress of our two novel, oral COVID-19 programs has put RedHill at the forefront of oral COVID-19 therapeutics development. Opaganib, one of the most advanced and promising novel, dual-mode of action, oral drug candidates in development for COVID-19, now has almost 100% enrollment in its global 464-patient Phase 2/3 study in severe COVID-19.
Mr. Ben-Asher continued: Commercially, a strong end to the first quarter has set up 2021 for growth, reversing a slow start to the year across the industry. Movantik s new prescriptions in the first quarter outperformed the same quarter last year, while Talicia s growth in prescription volume, repeat pres
EAGAN, Minn., May 26, 2021 /PRNewswire/ Today, Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members across 23 Blue Plans, unveiled MedDrive™ a new
Above the Law readers are offered 1 free CLE course each month, thanks to Lawline. See this month’s offering here.
From Lawline
Thank you for taking the time to talk with me today. Why don’t we start with sort of your career path that brought you to Prime Therapeutics.
During law school I worked for the City of Minneapolis. I was also working toward getting my master’s in public policy. That background and experience helped me get a job at the Minnesota Attorney General’s Office, and not only did it help me get the job, it allowed me to really hit the ground running when I got there. I was in healthcare licensing, we represented agencies responsible for regulating pharmacies, nurses, doctors, and other healthcare professions. We provided a wide range of advice. Sometimes we’d get calls saying, “The FDA is staging a raid, what do I do, what can I say?” I really enjoyed that job. Before I went to law school, I thought really seriously about going to pharmacy school, it
$EMOR
Healixa, Inc. (Stock Symbol: EMOR) is a Quickly Evolving Global Healthcare Company with Valuable New Pharmacy Assets and a Fintech Oriented Approach
EMERALD ORGANIC PRODUCTS INC (OTCMKTS:EMOR)
In the last several weeks, we have been asked repeatedly how Healixa will be able to logistically deliver patient scripts throughout the country. We have launched with an established rideshare also.” Ian Parker, CEO of EMOR
HOLBROOK, NEW YORK, UNITED STATES, May 12, 2021 /EINPresswire.com/ Healixa, Inc. (Stock Symbol: EMOR) is a Quickly Evolving Global Healthcare Company with Valuable New Pharmacy Assets and a Fintech Oriented Approach
a healthcare technology company delivering seamless and instant virtual care from your smartphone by combining healthtech and fintech to offer digital pharmacy, virtual patient monitoring and digital pharmacy subscription services,